Skip to content
Triangle logo TriangleGet started
← All settings

DISEASE & TREATMENT SETTING

Stage II recurrent Gallbladder Cancer

Source-derived catalogue. This is not a treatment recommendation or a personalised trial match.

Exact scope

Unresectable, recurrent, or metastatic (Stage II, Stage III, and Stage IV)

Broader topic: Gallbladder Cancer

Source population
Not part of this definition
Disease extent
recurrent
Treatment line
Not part of this definition
Stage
II
Resectability
unresectable
Biomarkers, prior therapy and derivation
molecular
    prior therapy
    1. class
      prior therapy
      status
      stated
    derivation status
    source-attested
    derivation note
    Scoped from an NCI treatment-summary heading. NCI PDQ is an evidence summary, not a practice guideline, and only the dimensions the heading states are part of this definition.
    source wording
    Unresectable, recurrent, or metastatic (Stage II, Stage III, and Stage IV)

    Study evidence for this setting

    1 linked studies · Applicability is a draft source assessment, not a determination of your eligibility.

    NCT02042443 · Registry condition search · Scope: unclear

    Trametinib or Combination Chemotherapy in Treating Patients With Refractory or Advanced Biliary or Gallbladder Cancer or That Cannot Be Removed by Surgery

    4 outcome links · 2 safety-group records · 0 quality-of-life measures

    →
    Source relationships and population-mapping limitations
    bindings
      mappings

        Download this complete draft source relationship record →

        Preserved source evidence · Not medical advice